What are the recommended treatment strategies for common electrolyte disturbances such as hyponatremia, hypernatremia, hypokalemia, hyperkalemia, hypocalcemia, hypercalcemia, and hypomagnesemia?

Treatment of Electrolyte Imbalances

Treatment of electrolyte disturbances must be guided by the underlying etiology, severity of the abnormality, rate of development, and clinical symptoms rather than laboratory values alone, with correction rates carefully controlled to prevent life-threatening complications such as osmotic demyelination syndrome or cardiac arrhythmias. 1, 2

General Principles of Management

Assessment Framework

• Categorize patients by volume status (hypovolemic, euvolemic, or hypervolemic) as this fundamentally determines treatment approach 2
• Monitor serum electrolytes, acid-base status, fluid balance, urine output, urine osmolarity, and urine electrolyte concentrations 1
• Measure serum urea, creatinine, electrolytes (sodium, potassium, bicarbonate), hematocrit, and blood urea nitrogen 1
• Check electrolytes at least every 48 hours in at-risk patients, or more frequently if clinically indicated 3
• In critically ill patients with acute kidney injury, perform electrolyte monitoring every 6-12 hours 3

Critical Monitoring Requirements

• Place patients with severe electrolyte abnormalities on continuous cardiac monitoring 1, 3
• Obtain 12-lead ECG immediately when severe hyperkalemia or other life-threatening electrolyte disturbances are suspected 3
• Monitor for at least 4-5 hours after any intervention, as arrhythmias can occur during this period even after initial treatment 3

---

Hyponatremia (Na <135 mmol/L)

Classification and Etiology

• Categorize by volume status: hypovolemic (fluid loss), hypervolemic (fluid retention from heart failure, cirrhosis, renal failure), or euvolemic (most often SIADH) 4, 2
• Rule out pseudohyponatremia from hyperproteinemia, hyperlipidemia, or hyperglycemia 4
• In neonates on parenteral nutrition, hyponatremia reflects absolute or relative water overload with sodium pool reduced, normal, or increased 1

Diagnostic Approach

• Assess intravascular volume and hydration status clinically 1
• Measure urinary sodium (uNa): <20 mmol/L suggests sodium depletion; >20 mmol/L with oliguria suggests acute renal failure 1
• ECF excess with inadequate postnatal weight loss suggests water overload 1
• ECF contraction with adequate weight loss suggests sodium depletion 1

Treatment Strategy

Severely Symptomatic Hyponatremia (Medical Emergency)

• Symptoms include: somnolence, obtundation, coma, seizures, or cardiorespiratory distress 2
• Administer bolus hypertonic saline to increase serum sodium by 4-6 mEq/L within 1-2 hours 2
• Critical correction limit: No more than 10 mEq/L increase within the first 24 hours 2
• Acute symptomatic exercise-induced hyponatremia requires urgent hypertonic saline 4

Chronic or Mild Hyponatremia

• Hypovolemic hyponatremia: Rehydrate with isotonic saline 4
• Hypervolemic hyponatremia: Address underlying cause (heart failure, cirrhosis, renal failure) 4
• Euvolemic hyponatremia: Restrict free water intake, treat underlying cause, consider vasopressin receptor antagonists 4, 2
• Urea and vaptans can be effective for SIADH and heart failure-related hyponatremia, though they have adverse effects 2

Critical Pitfall

• Corrections more rapid than 48-72 hours are associated with increased risk of pontine myelinolysis (osmotic demyelination syndrome) 1, 2
• Overly rapid correction occurs in 4.5-28% of cases and can result in parkinsonism, quadriparesis, or death 2

---

Hypernatremia (Na >145 mmol/L)

Etiology

• Most often occurs from water loss or inadequate water intake 4
• In very low birth weight infants, commonly results from incorrect replacement of transepidermal water loss, inadequate water intake, or excessive sodium intake 1
• Can be accompanied by dehydration, vomiting, diarrhea, renal insufficiency, or lack of antidiuretic hormone from intracranial metastasis 5

Clinical Manifestations

• Severe hypernatremia causes circulatory failure, muscular weakness, disorientation, convulsions, and coma 5

Treatment Approach

• Base therapeutic measures on etiology by assessing intravascular volume and hydration status 1
• In symptomatic hypovolemia, replace plasma volume first 1
• Correction rate: Reduce sodium by 10-15 mmol/L per 24 hours 1
• Depending on severity, use oral or intravenous hypotonic fluids 4
• Address the underlying cause 4

Critical Pitfall

• Rapid correction of hypernatremia may induce cerebral edema, seizures, and neurological injury 1

---

Hyperkalemia (K >6.0 mmol/L)

Etiology and Risk Factors

• May occur with or without impaired renal excretion 1
• Non-oliguric hyperkalemia in very low birth weight infants: lack of antenatal corticosteroids, systemic acidosis, birth asphyxia, massive hematomas, hemolysis, catabolic state 1
• Oliguric hyperkalemia: mostly due to renal failure with urine K <20 mmol/L 1
• Occurs in up to 65% of hospitalized patients with chronic kidney disease 3
• Tissue lesions, vomiting, diarrhea, and certain medications (potassium-sparing diuretics, ARBs, ACE inhibitors, NSAIDs) 6

Clinical Manifestations

• ECG changes: Peaking of T-waves, loss of P-waves, depression of ST segment, prolongation of QT interval 6
• Late manifestations: muscle paralysis and cardiovascular collapse from cardiac arrest (9-12 mEq/L) 6
• Bradycardia, ventricular fibrillation, or cardiac arrest 5
• Hyperkalemia is usually asymptomatic and manifested only by increased serum potassium and ECG changes 6

Treatment Protocol

Severe Hyperkalemia (K >7.0 mmol/L) - Requires Prompt Intervention

1. Immediate cardiac protection: Intravenous calcium gluconate if patient is at no risk or low risk of digitalis toxicity 6

2. Shift potassium intracellularly:

   • IV administration of 300-500 mL/hr of 10% dextrose solution containing 10-20 units crystalline insulin per 1,000 mL 6
   • Correction of acidosis with IV sodium bicarbonate if present 6

3. Eliminate potassium sources:

   • Discontinue foods and medications containing potassium 6
   • Stop potassium-sparing diuretics, ARBs, ACE inhibitors, NSAIDs, and nutritional supplements 6

4. Remove potassium from body:

   • Exchange resins, hemodialysis, or peritoneal dialysis 6

Special Considerations

• Rule out pseudohyperkalemia from hemolysis, inadequate phlebotomy technique, or repeated fist clenching before aggressive treatment 3
• In digitalized patients, too rapid lowering of serum potassium can produce digitalis toxicity 6
• Cardiovascular causes account for 40% of deaths in ESRD patients, with 20% being sudden cardiac death often triggered by hyperkalemia 3
• Severe hyperkalemia (>6.5 mmol/L) can contribute to acute kidney injury 3

---

Hypokalemia (K <3.5 mmol/L)

Etiology

• Enhanced demand (immaturity), electrolyte depletion (growth restriction), inadequate supply 1
• Loss of intestinal fluids from diarrhea or during diuretic administration 5
• Associated with increased ventricular dysrhythmias in heart failure patients 7

Clinical Manifestations

• Neural paralysis, though emergencies occur relatively infrequently 5
• Hypokalemia lowers the VF threshold and is associated with development of ventricular fibrillation 1
• Resolution of torsades de pointes with potassium replacement has been documented 1

Treatment

• Administer potassium chloride injections 5
• Monitor cardiac rhythm during replacement 1
• Address underlying cause (stop diuretics if appropriate, treat diarrhea) 1

---

Hypocalcemia

Etiology

• Renal insufficiency, vitamin D deficiency, hypothyroidism 5
• Hyperphosphatemia from reduced renal phosphate excretion leads to secondary hypocalcemia 3

Clinical Manifestations

• Classic presentation: tetanic spasms 5
• Can precipitate cardiac arrhythmias 3

Treatment

• Injection of calcium is effective treatment 5
• Critical consideration: During tetanic spasms, alkalosis may easily occur; treatment should only be provided after complete understanding of patient's acid-base status 5

---

Hypercalcemia

Etiology

• Hyperparathyroidism in cancer patients 5
• Rarely requires immediate intervention post-dialysis unless symptomatic 8

Clinical Manifestations

• Lassitude, tachycardia, nausea, vomiting, renal dysfunction 5
• Leads to neurological symptoms in severe cases 5

Treatment

• Injection of physiological saline solution 5
• Administration of calcitonin or mithramycin 5
• Avoid aggressive calcium supplementation in ESRD patients as this worsens vascular calcification 8

---

Hypomagnesemia

Clinical Significance

• Noted in advanced heart failure and can be accompanied by arrhythmias and refractory hypokalemia 7
• Low plasma magnesium associated with poor prognosis in cardiac arrest patients 1

Treatment Considerations

• No specific studies identified addressing correction of low magnesium in cardiac arrest 1
• Five RCTs and systematic review found no benefit from magnesium use in cardiac arrest 1
• Address underlying cause and replace magnesium in symptomatic patients 7

---

Special Populations and Contexts

Cardiac Arrest

• There are insufficient data to support or refute routine treatment of electrolyte abnormalities during cardiac arrest resuscitation 1
• Management is based on case reports and animal studies rather than randomized trials 1

Post-Dialysis ESRD Patients

• Dialysis effectively corrects most electrolyte abnormalities, particularly hyperkalemia, hyperphosphatemia, and acid-base disturbances 8
• Focus shifts from correction to monitoring for overcorrection after dialysis 8
• Check electrolytes 24 hours post-dialysis to assess for rebound abnormalities 8
• Avoid aggressive correction of post-dialysis electrolyte abnormalities as this can lead to dangerous fluctuations 8
• Monitor for symptoms rather than treating laboratory values alone 8

Missed Dialysis Sessions

• Check electrolytes immediately when ESRD patient presents after missing dialysis 3
• Obtain stat serum potassium, continuous cardiac monitoring, and 12-lead ECG immediately 3

Prevention of AKI from Electrolyte Disturbances

• Use balanced crystalloids instead of 0.9% normal saline for resuscitation to reduce AKI risk 3
• Hyperchloremia from 0.9% saline can directly cause AKI through decreased kidney perfusion 3
• The SALT trial showed balanced crystalloids reduced 30-day mortality and renal replacement therapy 3

Pediatric Parenteral Nutrition

• In parenterally fed infants and children, monitor serum electrolytes and weight daily for first days, then adapt intervals based on clinical stability 1
• Primary sodium depletion is frequent in preterm infants <34 weeks gestation due to deficient tubular reabsorption 1

---

Universal Pitfalls to Avoid

• Never treat laboratory values in isolation—always correlate with clinical symptoms, volume status, and rate of development 1, 2
• Avoid overly rapid correction of chronic electrolyte disturbances, particularly sodium 1, 2
• Always rule out pseudohyperkalemia before aggressive hyperkalemia treatment 3
• Remember that post-dialysis patients have wide electrolyte fluctuations—interpret values in context of dialysis timing 8
• In digitalized patients, rapid potassium correction can precipitate digitalis toxicity 6
• Extended-release potassium preparations mean absorption and toxic effects may be delayed for hours 6